Moreover, the inhibition of S100A8 proglycative function of S100A8 was proposed to be an appropriate therapeutic target in patients with anaplastic thyroid cancer. The gene discussed is S100A8; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.